Investegate | Company Announcement
Investegate announcements from EQS-Adhoc: Bayer Aktiengesellschaft: OCEANIC-AF study stopped early due to lack of efficacy
Stay updated with breaking news from Peter Dahlhoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from EQS-Adhoc: Bayer Aktiengesellschaft: OCEANIC-AF study stopped early due to lack of efficacy
EQSAdhoc Bayer Aktiengesellschaft Key word Change in Forecast Bayer Aktiengesellschaft Bayer lowers fullyear outlook 24Jul2023 1932 CETCEST Disclosure of an inside information acc to Article 17 MAR o
EQS-Ad-hoc: Bayer Aktiengesellschaft / Key word: Change in Forecast Bayer Aktiengesellschaft: Bayer lowers full-year outlook 24-Jul-2023 / 19:32 CET/CEST Disclosure of an...
EQS-Ad-hoc: Bayer Aktiengesellschaft / Key word(s): Personnel Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chair...
Investegate announcements from Bayer Aktiengesellschaft, Bayer announces five-point plan to effectively address potential future Roundup(TM) claims